Sean A. Gray

1.2k total citations
30 papers, 820 citations indexed

About

Sean A. Gray is a scholar working on Infectious Diseases, Parasitology and Ecology. According to data from OpenAlex, Sean A. Gray has authored 30 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Parasitology and 7 papers in Ecology. Recurrent topics in Sean A. Gray's work include Parasites and Host Interactions (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Parasite Biology and Host Interactions (5 papers). Sean A. Gray is often cited by papers focused on Parasites and Host Interactions (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Parasite Biology and Host Interactions (5 papers). Sean A. Gray collaborates with scholars based in United States, United Kingdom and Madagascar. Sean A. Gray's co-authors include Michael E. Konkel, Steve Garvis, Bong Jik Kim, Michael J. Feldhaus, Gerard A. Cangelosi, Robert W. Siegel, Keith D. Miller, Jane Weaver-Feldhaus, Michael E. Hume and Richard L. Ziprin and has published in prestigious journals such as PLoS ONE, Chemical Communications and Scientific Reports.

In The Last Decade

Sean A. Gray

26 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sean A. Gray United States 12 320 315 201 142 129 30 820
Harsh Vardhan Batra India 19 202 0.6× 458 1.5× 454 2.3× 52 0.4× 164 1.3× 93 1.2k
Helen S. Atkins United Kingdom 22 121 0.4× 210 0.7× 518 2.6× 51 0.4× 172 1.3× 61 1.4k
Mohammed Bahey-El-Din Egypt 18 158 0.5× 121 0.4× 259 1.3× 42 0.3× 87 0.7× 38 835
Manja Boehm Germany 14 370 1.2× 282 0.9× 225 1.1× 37 0.3× 86 0.7× 15 889
Gustavo Marçal Schmidt Garcia Moreira Brazil 16 33 0.1× 367 1.2× 273 1.4× 120 0.8× 95 0.7× 36 852
Patrick Kaiser Germany 18 334 1.0× 344 1.1× 307 1.5× 271 1.9× 86 0.7× 35 1.3k
H. G. Archie Bouwer United States 23 433 1.4× 142 0.5× 405 2.0× 52 0.4× 65 0.5× 40 1.6k
Benjamin Hoy Germany 13 139 0.4× 120 0.4× 342 1.7× 27 0.2× 74 0.6× 21 898
John Ikonomopoulos Greece 22 57 0.2× 276 0.9× 335 1.7× 123 0.9× 65 0.5× 54 1.2k
Anne M. Donachie United Kingdom 24 48 0.1× 285 0.9× 308 1.5× 117 0.8× 56 0.4× 29 1.3k

Countries citing papers authored by Sean A. Gray

Since Specialization
Citations

This map shows the geographic impact of Sean A. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean A. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean A. Gray more than expected).

Fields of papers citing papers by Sean A. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean A. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean A. Gray. The network helps show where Sean A. Gray may publish in the future.

Co-authorship network of co-authors of Sean A. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Sean A. Gray. A scholar is included among the top collaborators of Sean A. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean A. Gray. Sean A. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Lisa A., Rhea N. Coler, Gregory A. Deye, et al.. (2025). Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine. npj Vaccines. 10(1). 247–247.
3.
Larsen, Sasha E., Maham Rais, Valerie A. Reese, et al.. (2025). Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant. ImmunoHorizons. 9(6).
4.
Kalyanasundaram, Aravindan, Adebayo J. Molehin, Mumtaz Yaseen Balkhi, et al.. (2025). Potential biomarker and composite efficacy readout for human clinical trials of schistosomiasis vaccine in Africa. Scientific Reports. 15(1). 23251–23251.
5.
Balkhi, Mumtaz Yaseen, Yasuko Ono, Naoko Doi, et al.. (2025). A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine. npj Vaccines. 10(1). 48–48. 2 indexed citations
6.
Duggan, William P., et al.. (2024). Transanal minimally invasive surgery (TAMIS) for local excision of benign and malignant rectal neoplasia: a 7-year experience. Langenbeck s Archives of Surgery. 409(1). 32–32. 5 indexed citations
7.
Gray, Sean A., et al.. (2022). Are postoperative antibiotics required after orthognathic surgery?. International Journal of Oral and Maxillofacial Surgery. 52(2). 211–218. 3 indexed citations
8.
Lukehart, Sheila A., Barbara J. Molini, Charmie Godornes, et al.. (2022). Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum. Vaccine. 40(52). 7676–7692. 21 indexed citations
9.
Molehin, Adebayo J., Sean A. Gray, Jennifer Davis, et al.. (2021). Process Development of Sj-p80: A Low-Cost Transmission-Blocking Veterinary Vaccine for Asiatic Schistosomiasis. Frontiers in Immunology. 11. 578715–578715. 6 indexed citations
10.
Kim, Jiho, Émilie Vassal‐Stermann, Hongjie Wang, et al.. (2019). Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy. Scientific Reports. 9(1). 6169–6169. 8 indexed citations
11.
Hoeven, Neal Van, Steven R. Wiley, Emily Gage, et al.. (2018). A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen. npj Vaccines. 3(1). 39–39. 16 indexed citations
12.
Gray, Sean A., et al.. (2016). Translational Activities to Enable NTD Vaccines. Progress in molecular biology and translational science. 142. 291–315. 1 indexed citations
13.
Gray, Sean A., Margaret Moore, Richard A. Bowen, et al.. (2016). Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice. Antiviral Research. 131. 100–108. 6 indexed citations
14.
Grewal, Yadveer S., Muhammad J. A. Shiddiky, Sean A. Gray, et al.. (2013). Label-free electrochemical detection of an Entamoeba histolytica antigen using cell-free yeast-scFv probes. Chemical Communications. 49(15). 1551–1551. 57 indexed citations
15.
Gray, Sean A., John R. Barr, Suzanne R. Kalb, et al.. (2011). Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes. Biotechnology and Bioengineering. 108(10). 2456–2467. 4 indexed citations
16.
Gray, Sean A., Kris M. Weigel, Keith Miller, et al.. (2009). Flow cytometry‐based methods for assessing soluble scFv activities and detecting antigens in solution. Biotechnology and Bioengineering. 105(5). 973–981. 8 indexed citations
17.
Derby, Nina, Sean A. Gray, Elizabeth A. Wayner, et al.. (2007). Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. Virology. 366(2). 433–445. 23 indexed citations
18.
Tarun, Alice S., et al.. (2006). Quantitative isolation and in vivo imaging of malaria parasite liver stages. International Journal for Parasitology. 36(12). 1283–1293. 95 indexed citations
19.
Gray, Sean A. & Michael E. Konkel. (1999). Codon Usage in the A/T-Rich Bacterium Campylobacter Jejuni. Advances in experimental medicine and biology. 473. 231–235. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026